| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d0fc2b70675ee19bd5fc464f5ae9061 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0312
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0662 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0278
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0075 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06 |
| filingDate |
2020-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1931101960e60b0995c71406771237f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06621a6fe229e1792dde5f39f59d3a10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fabd41c8e424ddc1cfa6501be111f42e |
| publicationDate |
2021-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021132903-A1 |
| titleOfInvention |
Method by which brain with alzheimer's disease recovers from brain wave damage by using optogenetics |
| abstract |
The present invention relates to a method by which a brain with Alzheimer's disease recovers from brain wave damage by using optogenetics. The method by which a brain with Alzheimer's disease recovers from brain wave damage, of the present invention, does not directly damage neurons through photostimulation instead of electrostimulation, and uses optogenetics so as to specify inhibitory neurons related to brain wave damage caused by Alzheimer's disease, and then selectively use light through optogenetics so as to regulate the activity of damaged neurons, thereby enabling a brain with Alzheimer's disease to recover from damaged brain waves to a normal level. |
| priorityDate |
2019-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |